approval
savePYZCHIVA (USTEKINUMAB-TTWE) — FDA approval
community read0 votes
Sponsor: SAMSUNG BIOEPIS CO LTD. Form: INJECTABLE. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalNov 18, 2025 · 320d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalNov 18, 2025 · 320d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalJun 27, 2025 · 464d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalApr 30, 2025 · 522d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalApr 30, 2025 · 522d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalApr 30, 2025 · 522d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalMar 13, 2025 · 570d ago
- approvalPYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalMar 13, 2025 · 570d ago
same company · ±60 days · 6
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalDec 20, 2024
- approvalPYZCHIVA: PYZCHIVA (USTEKINUMAB-TTWE) — FDA approvalDec 20, 2024
- approvalEPYSQLI: EPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 21, 2025
- approvalEPYSQLI: EPYSQLI (ECULIZUMAB-AAGH) — FDA approvalNov 15, 2024
- approvalEPYSQLI: EPYSQLI (ECULIZUMAB-AAGH) — FDA approvalJan 28, 2025
- approvaldenosumab biosimilar: DENOSUMAB-DSSB — FDA approvalFeb 13, 2025
comments(0)
5-min edit window · permanent after that